{"id":"https://openalex.org/W2163485102","doi":"https://doi.org/10.1093/jnci/djv020","title":"Effect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers","display_name":"Effect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers","alternate_titles":[],"publication_year":2015,"publication_date":"2015-05-13","ids":{"openalex":"https://openalex.org/W2163485102","doi":"https://doi.org/10.1093/jnci/djv020","mag":"2163485102","pmid":"https://pubmed.ncbi.nlm.nih.gov/25972601"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/djv020","doi":"https://doi.org/10.1093/jnci/djv020","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/djv020","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2163485102"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022518836","display_name":"Mariano F. Zacar\u00edas Fluck","orcid":"https://orcid.org/0000-0002-7171-4268","observed_orcids":["https://orcid.org/0000-0002-7171-4268"]},"institutions":[{"id":"https://openalex.org/I11932220","display_name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","ror":"https://ror.org/0371hy230","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I11932220"]},{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. F. Zacarias-Fluck","raw_affiliation_strings":["Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain (JA). jarribas@vhio.net","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain (JA). jarribas@vhio.net","institution_ids":["https://openalex.org/I11932220","https://openalex.org/I123044942","https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086770050","display_name":"Beatriz Morancho","orcid":"https://orcid.org/0000-0003-3369-8647","observed_orcids":["https://orcid.org/0000-0003-3369-8647"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"B. Morancho","raw_affiliation_strings":["Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034914676","display_name":"Roc\u00edo Vicario","orcid":"https://orcid.org/0000-0002-7894-5261","observed_orcids":["https://orcid.org/0000-0002-7894-5261"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R. Vicario","raw_affiliation_strings":["Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052336042","display_name":"Antonio Luque-Garc\u00eda","orcid":"https://orcid.org/0000-0001-5785-8436","observed_orcids":["https://orcid.org/0000-0001-5785-8436"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Luque Garcia","raw_affiliation_strings":["Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053053038","display_name":"Marta Escorihuela","orcid":"https://orcid.org/0000-0001-9074-2339","observed_orcids":["https://orcid.org/0000-0001-9074-2339"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. Escorihuela","raw_affiliation_strings":["Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053250467","display_name":"Josep Villanueva","orcid":"https://orcid.org/0000-0003-1396-9470","observed_orcids":["https://orcid.org/0000-0003-1396-9470"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Villanueva","raw_affiliation_strings":["Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036020728","display_name":"Isabel Teresa Rubio","orcid":"https://orcid.org/0000-0003-0035-0679","observed_orcids":["https://orcid.org/0000-0003-0035-0679"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I. T. Rubio","raw_affiliation_strings":["Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077169627","display_name":"Joaqu\u00edn Arribas","orcid":"https://orcid.org/0000-0002-0504-0664","observed_orcids":["https://orcid.org/0000-0002-0504-0664"]},"institutions":[{"id":"https://openalex.org/I11932220","display_name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","ror":"https://ror.org/0371hy230","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I11932220"]},{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Arribas","raw_affiliation_strings":["Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain","Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain","Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain","institution_ids":["https://openalex.org/I123044942"]},{"raw_affiliation_string":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain","institution_ids":["https://openalex.org/I11932220"]},{"raw_affiliation_string":"Affiliations of authors:Preclinical Research (MZF, BM, RV, ALG, ME, JV, JA) and Clinical Research Programs (ITR), Vall d'Hebron Institute of Oncology , Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":1.9627,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.84194091,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"107","issue":"5","first_page":"djv020","last_page":"djv020"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.902999997138977},{"id":"https://openalex.org/keywords/oncogene-induced-senescence","display_name":"oncogene-induced senescence","score":0.9509999752044678},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/senescence-associated-secretory-phenotype","display_name":"senescence-associated secretory phenotype","score":0.9900000095367432},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8870000243186951},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.7580000162124634},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.5640000104904175},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5120000243186951},{"id":"https://openalex.org/keywords/il-6-inhibition","display_name":"IL-6 inhibition","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C522857546","wikidata":"https://www.wikidata.org/wiki/Q2070979","display_name":"Senescence","level":2,"score":0.7948843836784363},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5787339210510254},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5710897445678711},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.5630272030830383},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.513388991355896},{"id":"https://openalex.org/C97037327","wikidata":"https://www.wikidata.org/wiki/Q5334291","display_name":"Ectopic expression","level":3,"score":0.5068903565406799},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4999511241912842},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.45548975467681885},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.44790124893188477},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4126232862472534},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.41241228580474854},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.41096198558807373},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.34185945987701416},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2807461619377136},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.24813827872276306},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14776498079299927},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12621766328811646}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016922","descriptor_name":"Cellular Senescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018613","descriptor_name":"Microscopy, Confocal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jnci/djv020","doi":"https://doi.org/10.1093/jnci/djv020","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/djv020","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:25972601","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25972601","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W239602587","https://openalex.org/W1877364173","https://openalex.org/W1965493795","https://openalex.org/W1976639573","https://openalex.org/W1976858193","https://openalex.org/W1977800604","https://openalex.org/W1989805762","https://openalex.org/W1992094574","https://openalex.org/W1998767677","https://openalex.org/W2004273407","https://openalex.org/W2005248738","https://openalex.org/W2019276374","https://openalex.org/W2022746476","https://openalex.org/W2026890342","https://openalex.org/W2042140414","https://openalex.org/W2044341880","https://openalex.org/W2067117191","https://openalex.org/W2074819793","https://openalex.org/W2087999409","https://openalex.org/W2103315206","https://openalex.org/W2104397341","https://openalex.org/W2104728809","https://openalex.org/W2104816881","https://openalex.org/W2115585914","https://openalex.org/W2122804955","https://openalex.org/W2127433418","https://openalex.org/W2131078803","https://openalex.org/W2144499620","https://openalex.org/W2152059298","https://openalex.org/W2154799239","https://openalex.org/W2161322509","https://openalex.org/W2162942873","https://openalex.org/W2169790726","https://openalex.org/W2170725518","https://openalex.org/W2332827918"],"related_works":["https://openalex.org/W1913005661","https://openalex.org/W2122804955","https://openalex.org/W1569735112","https://openalex.org/W2789530892","https://openalex.org/W1605294665","https://openalex.org/W177286284","https://openalex.org/W3187827433","https://openalex.org/W2097141003","https://openalex.org/W2320181908","https://openalex.org/W1838745661"],"abstract_inverted_index":{"BACKGROUND:":[0],"Oncogene-induced":[1],"senescence":[2,27,62],"(OIS)":[3],"is":[4],"a":[5,16,45,54,87,189,193],"tumor":[6,90,159,211],"suppressor":[7],"mechanism.":[8],"However,":[9,60],"senescent":[10,84,130,141,178,194],"cells":[11,85,142,179,185,187,242],"remain":[12],"viable":[13],"and":[14,49,100,120,154,165,181,186],"display":[15],"distinct":[17],"secretome":[18,127],"(also":[19],"known":[20],"as":[21],"senescence-associated":[22],"secretory":[23],"phenotype":[24],"[SASP]":[25],"or":[26],"messaging":[28],"secretome,":[29],"[SMS])":[30],"that,":[31],"paradoxically,":[32],"includes":[33],"protumorigenic":[34],"factors.":[35],"OIS":[36],"can":[37,243],"be":[38],"triggered":[39],"by":[40,174,250,255,260],"ectopic":[41],"overexpression":[42],"of":[43,56,89,128,148,158,183,201,206,248],"HER2,":[44],"receptor":[46],"tyrosine":[47],"kinase":[48],"the":[50,126,175,204,207,246],"driving":[51],"oncogene":[52],"in":[53,67,145],"subtype":[55],"human":[57],"breast":[58,150],"cancer.":[59],"cellular":[61],"has":[63],"not":[64,172,253],"been":[65],"characterized":[66,125],"HER2-positive":[68,93,190,208],"tumors.":[69],"METHODS:":[70],"Using":[71,117],"an":[72],"approach":[73],"based":[74],"on":[75],"their":[76],"inability":[77],"to":[78,227,235,245,262],"proliferate,":[79],"we":[80,124],"isolated":[81],"naturally":[82,176],"occurring":[83,177],"from":[86,110,114,188],"variety":[88],"models":[91,147],"including":[92],"cells,":[94,257],"transgenic":[95],"mice":[96,107],"(n":[97,104],"=":[98,105,225,233,238],"3),":[99],"patient-derived":[101],"xenografts":[102],"(PDXs)":[103],"6":[106],"per":[108],"group":[109],"one":[111,115],"PDX":[112,191,209],"derived":[113],"patient).":[116],"different":[118,146],"biochemical":[119],"cell":[121],"biological":[122],"techniques,":[123],"these":[129,162,261],"cells.":[131,160],"All":[132],"statistical":[133],"tests":[134],"were":[135,168],"two-sided.":[136],"RESULTS:":[137],"We":[138],"found":[139],"that":[140],"arise":[143],"constantly":[144],"advanced":[149],"cancers":[151],"overexpressing":[152],"HER2":[153],"constitute":[155],"approximately":[156],"5%":[157],"In":[161],"models,":[163],"IL-6":[164,202],"other":[166],"cytokines":[167,252],"expressed":[169,196,254],"mainly,":[170],"if":[171],"exclusively,":[173],"(95.1%":[180],"45.0%":[182],"HCC1954":[184],"expressing":[192],"marker":[195],"IL-6,":[197],"respectively).":[198],"Furthermore,":[199],"inhibition":[200],"impaired":[203],"growth":[205,247],"(mean":[210],"volume":[212],"at":[213],"day":[214],"101,":[215],"control":[216],"vs":[217,229],"anti-huIL-6":[218],"treated,":[219],"332.2mm(3)":[220],"[95%":[221,231],"confidence":[222],"interval":[223],"{CI}":[224],"216.6":[226],"449.8]":[228],"114.4mm(3)":[230],"CI":[232],"12.79":[234],"216.0],":[236],"P":[237],".005).":[239],"CONCLUSIONS:":[240],"Senescent":[241],"contribute":[244],"tumors":[249],"providing":[251],"proliferating":[256],"but":[258],"required":[259],"thrive.":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2163485102","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
